ZACKS·2025-10-09 14:40Group 1 - Medpace (MEDP) has returned 59.8% year-to-date, significantly outperforming the Medical sector, which has gained about 1.8% on average [4] - Medpace holds a Zacks Rank of 2 (Buy), indicating a positive earnings outlook with a consensus estimate for full-year earnings moving 10.4% higher in the past quarter [3] - The Medical Services industry, to which Medpace belongs, has lost an average of 0.3% so far this year, further highlighting Medpace's strong performance [5] Group 2 - Black Diamond (BDTX) is another Medical stock that has outperformed the sector with a year-to-date return of 86.5% and holds a Zacks Rank of 1 (Strong Buy) [4][5] - The Medical - Biomedical and Genetics industry, which includes Black Diamond, has gained 8.7% year-to-date and is currently ranked 96 [6] - Investors interested in Medical stocks should closely monitor both Medpace and Black Diamond for continued strong performance [6]